Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Cancer. 2008 Jul 15;113(2):293–301. doi: 10.1002/cncr.23552

TABLE 1.

Characteristics of Patients Treated With High-dose Interleukin-2

Characteristic No. of patients
Total 259 100%
Sex
Male 180 69%
Female 79 31%
Age, y
11–20 2 1%
21–30 11 4%
31–40 32 12%
41–50 92 36%
51–60 92 36%
61–70 30 12%
ECOG performance status
0 198 76%
1 50 19%
2 10 4%
3 1
Prior treatment
None 6 2%
Surgery 250 97%
Chemotherapy 16 6%
Radiotherapy 23 9%
Hormonal 7 3%
Immunotherapy 38 15%
Any 2 or more 66 25%
Any 3 or more 15 6%

ECOG indicates Eastern Cooperative Oncology Group.